Americafirst Capital Management buys $2,141,682 stake in Agilent Technologies Inc (A)

Agilent Technologies Inc (A) : Americafirst Capital Management scooped up 3,436 additional shares in Agilent Technologies Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 18, 2016. The investment management firm now holds a total of 45,558 shares of Agilent Technologies Inc which is valued at $2,141,682.Agilent Technologies Inc makes up approximately 1.48% of Americafirst Capital Management’s portfolio.

Other Hedge Funds, Including , Cribstone Capital Management added A to its portfolio by purchasing 2,305 company shares during the most recent quarter which is valued at $108,358. Agilent Technologies Inc makes up approx 0.07% of Cribstone Capital Management’s portfolio.Btr Capital Management Inc reduced its stake in A by selling 720 shares or 11.98% in the most recent quarter. The Hedge Fund company now holds 5,290 shares of A which is valued at $247,572. Agilent Technologies Inc makes up approx 0.06% of Btr Capital Management Inc’s portfolio.Chevy Chase Trust Holdings boosted its stake in A in the latest quarter, The investment management firm added 2,738 additional shares and now holds a total of 282,686 shares of Agilent Technologies Inc which is valued at $12,856,559. Agilent Technologies Inc makes up approx 0.07% of Chevy Chase Trust Holdings’s portfolio. Ct Financial Advisors sold out all of its stake in A during the most recent quarter. The investment firm sold 500 shares of A which is valued $22,740.

Agilent Technologies Inc opened for trading at $46.96 and hit $47.18 on the upside on Wednesday, eventually ending the session at $47.01, with a gain of 0.06% or 0.03 points. The heightened volatility saw the trading volume jump to 21,24,914 shares. Company has a market cap of $15,303 M.

On the company’s financial health, Agilent Technologies Inc reported $0.44 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on May 16, 2016. Analyst had a consensus of $0.39. The company had revenue of $1019.00 million for the quarter, compared to analysts expectations of $983.35 million. The company’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.38 EPS.

Many Wall Street Analysts have commented on Agilent Technologies Inc. Company shares were Reiterated by Jefferies on May 17, 2016 to “Buy”, Firm has raised the Price Target to $ 51 from a previous price target of $46 .Company shares were Reiterated by Barclays on May 17, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 45 from a previous price target of $42 .

Agilent Technologies Inc. is engaged in the life sciences diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments software services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business the diagnostics and genomics business and the Agilent CrossLab business. The Company’s life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment consists of three businesses: the Dako business the genomics business and the nucleic acid solutions business. The Company’s Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *